Mergers & Acquisitions - Pharmaceutical, AbbVie

Filter

Current filters:

PharmaceuticalAbbVie

Popular Filters

AbbVie board withdraws bid to acquire Shire

AbbVie board withdraws bid to acquire Shire

16-10-2014

Following takeover target Shire’s waiver of the three-day notice period, AbbVie said this morning that…

AbbVieIrelandMergers & AcquisitionsPharmaceuticalShireUSA

AbbVie reconsidering $54.6 billion acquisition of Shire

AbbVie reconsidering $54.6 billion acquisition of Shire

15-10-2014

US drugmaker AbbVie has told Ireland-headquartered Shire of its board of directors' intention to meet…

AbbVieFinancialIrelandMergers & AcquisitionsPharmaceuticalShire

Shire finally accepts AbbVie’s takeover offer

Shire finally accepts AbbVie’s takeover offer

18-07-2014

After a protracted and at times hostile courtship, Ireland-headquartered drugmaker Shire has finally…

AbbVieHumiraMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

14-07-2014

Ireland-headquartered Shire, which just on Friday confirmed it had finally entered talks with suitor…

AbbVieAdalimumabFinancialIrelandMergers & AcquisitionsPharmaceuticalShireUSA

Shire confirms it has entered into talks with AbbVie

Shire confirms it has entered into talks with AbbVie

12-07-2014

Following reports by the Bloomberg news service, on Friday Ireland-based drugmaker Shire confirmed that…

AbbVieIrelandMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

AbbVie comes up with higher offer for Shire of $51.5 billion

AbbVie comes up with higher offer for Shire of $51.5 billion

08-07-2014

As has been widely expected following the meetings last week with major shareholders of Ireland headquartered…

AbbVieMergers & AcquisitionsPharmaceuticalShire

Analysts view Shire defense as independent pharma

Analysts view Shire defense as independent pharma

24-06-2014

There has been quite a lot of reaction to yesterday’s presentation by Ireland-headquartered Shire's…

AbbVieMergers & AcquisitionsPharmaceuticalShire

Shire sets out robust defense for rejecting AbbVie takeover bid

Shire sets out robust defense for rejecting AbbVie takeover bid

23-06-2014

Ireland-headquartered Shire today presented a robust defense of its position as an independent pharmaceutical…

AbbVieMergers & AcquisitionsPharmaceuticalShire

Shire rejects unsolicited $46.5 billion takeover offer from AbbVie

Shire rejects unsolicited $46.5 billion takeover offer from AbbVie

20-06-2014

Ireland headquartered Shire has this morning revealed that it has received, and rejected, an unsolicited…

AbbVieMergers & AcquisitionsPharmaceuticalShire

Pharmstandard may sell its non-Rx business for $2.5 billion; AbbVie Russian plans

02-07-2013

Pharmstandard, Russia's largest drug producer, is considering selling its production of non-prescription…

AbbVieEuropeMergers & AcquisitionsPharmaceuticalPharmstandardProductionR-Pharma

AbbVie selected as name for Abbott research-based spin out

22-03-2012

Confirming its previous announcements on plans to split the US health care major, Abbott Laboratories…

Abbott LaboratoriesAbbVieMergers & AcquisitionsPharmaceutical

Parexel

Parexel

Back to top